Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation

Abstract Background/Introduction Targets set by Public Health England (PHE) state that 90% of patients with atrial fibrillation (AF) are expected to receive anticoagulation 2029. In 2019/2020, across three London boroughs serving a population 770,000, the percentage AF at high risk stroke (CHA2DS2VASc>2) anticoagulated was below target PHE. addition, optimisation factors can significantly reduce cardiovascular disease and associated mortality in these patients. Purpose To provide specialist input from pharmacist prevent AF-related strokes through improvement rates over one year, as well minimising bleed on dual antithrombotic therapy. Methods A commissioned identify high-risk working primary care clinicians. Utilising “proactive frameworks” created UCLPartners Clinical Effectiveness Group Queen Mary University London, were stratified prioritised for review. Patients not deemed be highest risk, requiring an urgent review assess suitability anticoagulation. virtual multidisciplinary team (MDT) would any complex agree action plan. therapy also assessed determine if antiplatelet indicated minimise major bleeding. All reviewed statin initiation optimise prevention. Results At baseline, 86% (7581/8582) CHA2DS2VASc>2 anticoagulated. 1001 pharmacist, 84% (841/1001) having CHA2DS2VASc between 2–5, 28% (280/1001) monotherapy. Analysis 12 months following intervention reported 95% (7888/8280) suitably anticoagulated, 9%. 6% (61/1001) switched antiplatelets 25% (246/1001) newly initiated 13% (130/1001) required MDT appropriateness initiation. There reduction 429 252 (41% reduction). Lastly those reviewed, 2609 received recommendation start either (n=1981) or secondary prevention (n=628). Conclusion(s) Provision supported workforce improve this people all boroughs. By extrapolating results nationally, 3600 could averted 18 months. Funding Acknowledgement Type funding sources: None.